ABOUT US

Who we are

Carexso is the foremost organization for site management in the Middle East and Africa

With a proven track record of over 20 years in facilitating market authorization for new and innovative treatments across more than 30 therapeutic areas. Our dedicated team and agile approach allow us to efficiently collaborate with pharmaceutical companies, biotechnology companies, clinical research sites, contract research organizations (CROs), and other stakeholders to ensure standardized operations, reduced variability in site performance, and improved predictability in clinical trial enrollment and data quality.At Carexso, we employ a well-defined framework that prioritizes:
  • Leveraging data, innovation, and technology to advance clinical research.
  • Providing resources and services to advance research and inform clinical practice.
  • Standardizing institutional policies and processes, enhancing quality through experience sharing and ongoing training.
  • Improving financial management and introducing efficiencies to clinical trials.
Our commitment to these principles allows us to facilitate greater access to innovative treatments for patients in the Middle East and Africa. We remain steadfast in our dedication to advancing the field of clinical research through excellence in site management.
What we do

Carexso Provide Comprehensive Services

Carexso provides comprehensive operational and administrative support services to clinical investigators at research sites, encompassing everything from feasibility assessments and start-up activities to patient recruitment and data collection. Additionally, we offer support for study initiation, monitoring, and closeout activities.

To facilitate clinical trials, we assign highly trained Clinical Research Coordinators (CRCs) to each research site, specifically dedicated to a particular protocol. This approach reduces the operational burden on investigators who are often consumed with routine clinical work.

With human resource shortages plaguing many institutions, our trained and experienced research coordinators offer a broad range of capabilities to execute each clinical trial with the utmost standards of quality and ethics. By partnering with Carexso, clinical investigators can focus on delivering exceptional patient care while we take care of the operational and administrative aspects of clinical trials, enabling them to run more efficiently and effectively.

Carexso boasts an international team of highly skilled professionals with expertise in site management, development, outcome, and excellence.

Our Mission

To leverage data, analytics, and technology in an integrated value-based approach to drive innovation and advance clinical research.

Our Vision

To empower clinical research in the region and drive progress towards groundbreaking treatments and potential cures.

UAE

Saudia Arabia
Egypt

Dr. Walid Abbas Zaher​

Co-Founder & Chief Executive Officer at Carexso
Dr. Walid Zaher brings a profound wealth of experience and expertise to the forefront of CareXso, a journey that seamlessly interweaves clinical excellence, advanced education, and groundbreaking research leadership.

Dr. Walid Zaher’s vision for CareXso transcends geographical borders, envisioning the Middle East and Africa (MEA) as integral players in the global clinical research network. His resolute commitment to fostering diversity and inclusivity within the healthcare industry and his tireless pursuit of health innovation exemplify his transformative leadership. As he continues to shape the healthcare landscape, Dr. Zaher stands as a beacon of progress and a driving force in the quest for a healthier, more equitable world.

In the United Arab Emirates (UAE), Dr. Zaher emerged as a transformative figure, directing pioneering research initiatives at SEHA and subsequently serving as Chief Research Officer at G42 Healthcare and CEO at IROS. Amid the unprecedented challenges posed by the COVID-19 pandemic, he demonstrated unwavering resilience by establishing the UAE’s inaugural Contract Research Organization, building upon the resounding success of the 4Humanity Clinical Trial.

Before his UAE sojourn, Dr. Zaher held prestigious positions, including Director of the College of Medicine Research Centers and an assistant professorship in regenerative medicine and stem cells at King Saud University in Riyadh. His expertise extended to consulting on the Saudi 2020 National Biotechnology and Infectious Disease plan at KASCT.

Fuelled by an unrelenting desire to expand the horizons of medical knowledge, Dr. Zaher embarked on an academic odyssey, earning a Bachelor of Medicine and Surgery in Saudi Arabia. His yearning for innovation led him to pursue further education, culminating in a Master’s in Medical Education, Anatomy and Embryology, and Bioscience Technology. This foundation enabled him to transcend conventional boundaries, culminating in a Ph.D. in Regenerative Medicine from Denmark. His quest for excellence also led him to Harvard-MGH, Boston, where he acquired specialized training in laser-medicine application.

OUR TEAM

Rita El Ojeil
Chief operating officer
Dr. Mary Roushdy
HEOR Director
Mohamed Ali
CLINICAL SITE OPERATION DIRECTOR
Majda Ammar Khodja
Senior consulting and analytics manager
Maha Elhoofy
Quality and Compliance Director
Mostafa Abdrabo
BD Manager
Ahmed Barakat
Finance Manager
Erica Maliksi
Executive Assistant
Rita Ojeil
MARKET ACCESS and HEALTH ECONOMICS & OUTCOMES RESEARCH DIRECTOR
Ahmed Heiba
Business Development Associate Director
Scroll to Top